News & Events

Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics’ PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

Dec 02, 2024 | 09:30 ET

Connect with 
Gannet BioChem

"*" indicates required fields

* indicates required fields
This field is for validation purposes and should be left unchanged.